Tweet
<img alt="" height="1" width="1" />
Cardiovascular Outcome Studies in Diabetes Drugs Finally Arrive
Forbes
For many years critics have bemoaned the absence of outcome studies for the many diabetes drugs used to lower blood glucose levels. Now, finally, two large trials with different drugs have been presented at the European Society of Cardiology meeting in ...
ESC: Diabetes Drugs No Help for HeartMedPage Today
Takeda EXAMINE Cardiovascular Safety Outcomes Trial of Alogliptin Met ...MarketWatch
Treatment with the anti-diabetic drug alogliptin does not increase CV risk in ...EurekAlert (press release)
all 5 news articles »
More...